Clinical Trials Browser

Phase 1 × Glioblastoma × paclitaxel-Angiopep-2 conjugate × Clear all

NCT00539344 2014-07-31

A Phase 1, Open-Label, Dose Escalation Study of ANG1005 in Patients With Malignant Glioma

Phase 1 Completed

Astrocytoma, Glioblastoma, Oligodendroglioma, Recurrence